The Reporting Persons are filing this Amendment No. 9 to provide an update as to its intentions with respect to the Company. Item 4 of the Amended Statement is hereby amended and restated in its entirety as follows: Stock Purchase Agreement On December 30, 2025, the Company entered into a stock purchase agreement (the "Purchase Agreement") with David Hoffmann (the "Anchor Investor") and certain additional investors (the "Additional Investors" and, together with the Anchor Investor, the "Investors"), pursuant to which the Company agreed to issue and sell to the Investors in a private placement (the "Private Placement") an aggregate of 15,384,615 shares (the "Shares") of the Company's common stock, par value $0.01 per share (the "Common Stock"), at a purchase price of $3.25 per Share. Pursuant to the terms of the Purchase Agreement, the Company held a special meeting of its stockholders on February 2, 2026 (the "Special Meeting") to obtain approval of (i) the proposed issuance of the Shares in the Private Placement for purposes of Nasdaq Listing Rules 5635(b) and 5635(d), and (ii) a proposal to amend the Company's amended and restated certificate of incorporation (the "Charter Amendment") to increase the number of shares of Common Stock authorized for issuance from 12,000,000 to 40,000,000 shares (such proposals, the "Transaction Proposals"). The Transaction Proposals were approved by the stockholders at the Special Meeting. On February 5, 2026, the Company closed (the "Closing") the Private Placement and, pursuant to the terms of the Purchase Agreement sold an aggregate of 15,384,615 Shares at a purchase price of $3.25 per Share to the Investors, including 10,909,440 to the Anchor Investor. In connection with the Closing, pursuant to the terms of the Purchase Agreement, the Company issued an additional 615,384 Shares to the Anchor Investor's advisor as reimbursement of certain of the Anchor Investor's expenses at a price of $3.25 per Share. As a result of the Private Placement, the Anchor Investor and the other Reporting Persons hold an aggregate 11,528,340 Shares, approximately 51.82% of the Company's outstanding Common Stock as of the date of the Closing. Pursuant to the terms of the Purchase Agreement, the Investors agreed to a lock-up with respect to the Shares for a period of 180 days and standstill period of twelve months, subject to certain exceptions. With respect to the standstill, certain Investors, including the Anchor Investor, are each able to purchase up to 600,000 shares of Common Stock during the standstill period. Pursuant to the terms of the Purchase Agreement, upon the Closing, the Anchor Investor was appointed as a member and as the Chairman of the Company's Board of Directors (the "Board"). The size of the Board is expected to be increased from nine to ten members, with one individual who is mutually agreeable to the Anchor Investor and the Company expected to be designated for nomination or otherwise appointed to serve on the Board. The Private Placement is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2) of the Securities Act and in reliance on similar exemptions under applicable state laws. The Company is relying on this exemption from registration based in part on representations made by the Investors. At the time of issuance, the Shares were not registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (the "SEC") or an applicable exemption from the registration requirements. The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, a copy of which is incorporated herein by reference to Exhibit 99.1 to the Schedule 13D/A filed by the Reporting Persons on January 2, 2026. Registration Rights Agreement Pursuant to the terms of the Purchase Agreement, at the Closing, the Company and the Investors entered into a registration rights agreement (the "Registration Rights Agreement"), pursuant to which the Company agreed to provide certain customary registration rights, including the registration of the Shares for resale. The Company is required to use commercially reasonable efforts to file a registration statement with the SEC covering the resale by the Investors of their Shares within 60 days following the Closing. The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Registration Rights Agreement, a copy of which is incorporated by reference to Exhibit 99.2 to the Schedule 13D/A filed by the Reporting Persons on January 2, 2026. The Reporting Persons intend to review their investmnt in the Issuer on a continuing basis. Depending on various factors, the Issuer's finanical position, results and strategic, actions taken by the Issuer's management and Board, price levels of the Issuer's Common Stock, and other investment opportunities available to the Reorting Person, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as the deem appropriate, including, without limitation, acquiring additional Common Stock and/or other equire or other securities of the Issuer or disposing of some or all of the securities beneficially owned by them in the public market or privately negotiated transactions (to the extent permissible under th terms of the Purchase Agreement) and/or otherwise changing their intention with respect to any and all matters refered to in Item 4 of Schedule 13D.